Bicara Therapeutics (BCAX) EPS (Basic) (2023 - 2026)
Bicara Therapeutics (BCAX) posted quarterly EPS (Basic) of -$0.93 for Q1 2026, down 36.83% year-over-year from -$1.47 in Q1 2025, and down 135295.92% quarter-over-quarter from -$0.0 in Q4 2025.
Bicara Therapeutics (BCAX) EPS (Basic) (2023 - 2026) Analysis & Trends
Bicara Therapeutics' EPS (Basic) history runs 4 years deep, the most recent figure standing at -$0.93 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 36.83% year-over-year to -$0.93; the TTM figure through Mar 2026 stood at -$2.59 (down 52.81% YoY), while the FY2025 annual figure was -$0.0, up 37.64% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.93, down from -$0.0 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.0 in Q4 2025, with the low at -$38.23 in Q3 2023.
- The 4-year median for EPS (Basic) is -$0.68 (2025), against an average of -$7.33.
- The sharpest annual moves came in 2025 and 2026: EPS (Basic) jumped 97.36% in 2025, then tumbled 36.83% in 2026.
- Bicara Therapeutics' EPS (Basic) stood at -$0.02 in 2023, then surged by 94.18% to -$0.0 in 2024, then surged by 45.17% to -$0.0 in 2025, then tumbled by 135295.92% to -$0.93 in 2026.
- Business Quant data shows BCAX's EPS (Basic) at -$0.93 in Q1 2026, -$0.0 in Q4 2025, and -$0.67 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Bicara Therapeutics | 1.60 Bn | 1.60 Bn | - | -0.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.82 |
| Mar 31, 2026 | -0.93 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -0.67 |
| Jun 30, 2025 | -0.50 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | -1.60 |
| Jun 30, 2024 | -19.01 |
| Mar 31, 2024 | -18.94 |
| Dec 31, 2023 | -0.02 |
| Sep 30, 2023 | -38.23 |